Clinical Trials in Cleveland

Showing 1521-1540 of 9,497 trials

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

NCT06689839

The objective of this study is to compare the safety and effectiveness of the F2 Cerebral Protection System (CPS) to a standard of care control group in patients undergoing Transcatheter Aortic Valve Replacement (TF TAVR)

Aortic Stenosis Treated With TAVIAortic Diseases

EnCompass Technologies, Inc.500 participantsStarted Sep 2025

Naples, Florida, United States • Indianappolis, Indiana, United States • Detroit, Michigan, United States +7 more locations

Active Not RecruitingPhase 3< 1 mile

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

NCT05450692

This study will assess the efficacy and safety of the combination of ceralasertib and durvalumab versus standard of care docetaxel in patients with locally advanced and metastatic NSCLC after progression on prior anti-PD-(L)1 therapy and platinum-based chemotherapy.

Advanced or Metastatic Non-Small Cell Lung Cancer

AstraZeneca594 participantsStarted Sep 2022

Mobile, Alabama, United States • Chandler, Arizona, United States • Los Alamitos, California, United States +190 more locations

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Find Trials by Condition in Cleveland

Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

Study of AVZO-021 in Patients With Advanced Solid Tumors

CAE for Poorly Adherent Individuals With Schizophrenia

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

The Synergy Disc To Anterior Cervical Discectomy and Fusion

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis

Allergic Disease Onset Prevention Study

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)

A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site

Pharmacogenomics for Better Treatment of Fungal Infections in Cancer